CD36 mediates the innate host response to beta-amyloid

Joseph B El Khoury1, Kathryn J Moore, Terry K Means

  • 1Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Insights

CD36, a receptor on immune cells, triggers inflammation in Alzheimer's disease (AD) by binding to beta-amyloid. Blocking CD36 reduces inflammatory responses and cell recruitment in AD models.

Area of Science:

  • Neuroscience
  • Immunology
  • Alzheimer's Disease Research

Background:

  • Microglia activation and inflammation are central to Alzheimer's disease (AD) pathogenesis.
  • Beta-amyloid fibrils are known triggers of this inflammatory response.
  • The precise molecular mechanisms linking beta-amyloid to microglial activation remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms of fibrillar beta-amyloid-induced inflammatory response in microglia.
  • To investigate the role of CD36, a scavenger receptor, in mediating microglial and macrophage activation by beta-amyloid.

Main Methods:

  • Utilized CD36 null mice and wild-type littermates.
  • Isolated microglia and macrophages for in vitro stimulation with fibrillar beta-amyloid.
  • Assessed cytokine, chemokine, and reactive oxygen species secretion.
  • Evaluated inflammatory cell recruitment in vivo following beta-amyloid administration.

Main Results:

  • Microglia and macrophages from CD36 null mice showed significantly reduced inflammatory mediator secretion upon beta-amyloid exposure.
  • CD36 null mice exhibited markedly decreased recruitment of macrophages and microglia to sites of beta-amyloid injection.
  • CD36 was identified as a key mediator of the innate immune response to beta-amyloid.

Conclusions:

  • CD36 acts as a crucial pattern recognition receptor mediating the inflammatory response of microglia and macrophages to beta-amyloid.
  • CD36 plays a significant role in the pro-inflammatory events contributing to Alzheimer's disease.
  • Targeting CD36 may offer a therapeutic strategy for mitigating neuroinflammation in AD.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...